Blog
Reddit Stock is Crashing: Is This a Generational Buying Opportunity?
Reddit (NYSE: RDDT) is one of the fastest-growing social media companies in the world.
*Stock prices used were the afternoon prices of March 19, 2026. The video was published on March 21, 2026.
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
On February 17, 2026, FCPM III Services B.V. disclosed a buy of 1,489,096 RAPT Therapeutics (NASDAQ:RAPT) shares, an estimated $46.24 million trade based on quarterly average pricing.
According to
Why Is SoFi Stock Crashing, and Should You Buy the Dip?
For several months, I had been warning investors that SoFi (NASDAQ: SOFI) stock was too expensive. Since my warnings, the stock has crashed to lower levels.
*Stock prices used were the afternoon
Is This Stock a Buy on the Dip?
After becoming the first healthcare stock to hit a $1 trillion market valuation in late 2025, Eli Lilly (NYSE: LLY) hasn't performed well since, with its shares down about 19% from their 52-week
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
Kynam Capital Management disclosed in a February 17, 2026, SEC filing that it sold 1,720,949 shares of Cogent Biosciences (NASDAQ:COGT), an estimated $48.38 million trade based on quarterly average
Bristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?
Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
On March 2, 2026, Jennifer Dawn Whalen, SVP, CFO of Bristow
Uber's Advertising Business May Be Bigger Than Investors Think
Investors typically think of Uber Technologies (NYSE: UBER) as a ride-hailing and food delivery company. And for good reason -- those businesses still drive the majority of its revenue and growth.
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
Kynam Capital Management trimmed its stake in Viridian Therapeutics (NASDAQ:VRDN), selling 2,957,386 shares in the fourth quarter, an estimated $81.11 million transaction based on quarterly average
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know
Kynam Capital Management reduced its position in CG Oncology (NASDAQ:CGON), selling 1,059,375 shares in the fourth quarter for an estimated $43.84 million based on quarterly average pricing
This Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026
Nuclear energy is being considered as a potential solution to the incredible demand for electricity created by artificial intelligence (AI) and the data centers it requires.
By 2028, according to
Before Retiring, Warren Buffett Left Investors With a $373 Billion Warning. Here's What History Says the Stock Market Will Do Next.
Warren Buffett stepped down as CEO of Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) at the start of the year, but his legacy will live on forever. In just over 60 years at the helm of the company, he
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish
Kynam Capital Management disclosed in a February 17, 2026, Securities and Exchange Commission (SEC) filing that it sold 469,041 shares of Syndax Pharmaceuticals (NASDAQ:SNDX), an estimated $8.18
Is Berkshire Hathaway Stock a Buy Right Now?
It is a new era in Omaha, as investing legend Warren Buffett retired at the end of 2025 after roughly 60 years leading Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) and growing it into one of the
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
According to an SEC filing dated February 17, 2026, DAFNA Capital Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 34,405 shares during the fourth quarter of 2025. The
EV Stocks Have Massive Upside, but Investors Need to Avoid This Profit Blackhole
Getting into global trends early, one way or another, is an ideal way to find lucrative long-term investment wins -- but it's certainly easier said than done. Electric vehicle (EV) makers have
Better Semiconductor Stock: Broadcom vs. Marvell Technology
Artificial intelligence (AI) infrastructure spending is booming, and hyperscalers (owners of large data centers) are increasingly looking to turn to custom AI chips called ASICs
Got $5,000? 2 Beaten-Down Tech Stocks Smart Money Is Quietly Accumulating
After an AI-fueled run caused many big-name tech companies to shoot up in value over the past few years, it has been a slow start to 2026 for most of them. As of market open on March 18, all of the
Brightlight Capital Cuts Hilton Grand Vacations Stake to $13.6 Million
According to a recent SEC filing dated February 17, 2026, Brightlight Capital Management Lp reduced its stake in Hilton Grand Vacations (NYSE:HGV), by 79,500 shares. The fund’s quarter-end position
Microsoft Is Now the Cheapest "Magnificent Seven" Stock. Does That Make It a Buy?
To some investors, it may come as a shock that Microsoft (NASDAQ: MSFT) is now the cheapest stock in the "Magnificent Seven" as measured by price-to-earnings ratio. Its earnings multiple of 25 is
Harley-Davidson Executive Sells Over 4,000 Shares
A senior executive at Harley-Davidson, a global motorcycle manufacturer, sold shares amid a year of share price declines.
On March 12, 2026, Charles Do, a Harley-Davidson (NYSE:HOG) Senior Vice
I Just Put More Than $10,000 Into These 3 Tech Stocks. Here's Why.
This year, I've put nearly $15,000 to work buying three tech stocks to add to my personal portfolio. Let's dig into why I like these three stocks.
My most recent buy has been shares of Advanced
3 Green Energy Stocks to Buy in March
Oil prices are in the news thanks to the geopolitical conflict unfolding in the Middle East. That's pushed longer-term trends in the energy sector into the background. But the multi-decade shift
Meta Stock Slips Below $600. Time to Buy?
Down about 25% from an all-time high of nearly $800, shares of Meta Platforms (NASDAQ: META) have been slammed. As of this writing, the stock has slipped below $600.
Yet the underlying business is
2 Beaten-Down Stocks That Still Aren't Worth Buying
It's often wise to wait until a significant correction before investing in a stock. However, that strategy only works when the company can recover from whatever obstacle led to the sell-off. When
The Hidden Advantage of Roth IRAs Retirees Don't Appreciate Until It's Too Late
There's a reason Roth IRAs tend to get a lot of attention. They offer tax-free gains on investments and tax-free withdrawals in retirement. They also don't force savers to take required minimum


